HbF program(MiNA Therapeutics)

N/A

Report date: 2025/08/13 13:35:58
NME

Base Information

Drug NameHbF program(MiNA Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRNA interferenceFetal hemoglobin modulators
TargetsFetal hemoglobin
Therapy Area/Indicationsbeta-ThalassemiaAnemia, Sickle Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMina Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMina Therapeutics Ltd
Inactive CompaniesN/A
Active Indicationsbeta-ThalassemiaAnemia, Sickle Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A